These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34125711)

  • 1. Quality Control: Testing for "Micromonsters": Viable Air and Surface Sampling in Aseptic Compounding.
    Mulder K
    Int J Pharm Compd; 2021; 25(3):211-216. PubMed ID: 34125711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excipient Stability in Oral Solid Dosage Forms: A Review.
    Darji MA; Lalge RM; Marathe SP; Mulay TD; Fatima T; Alshammari A; Lee HK; Repka MA; Narasimha Murthy S
    AAPS PharmSciTech; 2018 Jan; 19(1):12-26. PubMed ID: 28895106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenge of paediatric compounding to solid dosage forms sachets and hard capsules - Finnish perspective.
    Sivén M; Kovanen S; Siirola O; Hepojoki T; Isokirmo S; Laihanen N; Eränen T; Pellinen J; Juppo AM
    J Pharm Pharmacol; 2017 May; 69(5):593-602. PubMed ID: 27704551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the dissolution characteristics of capsule and tablet dosage forms of melt granulations of paracetamol--diluent effects.
    Uhumwangho MU; Okor RS
    Acta Pol Pharm; 2007; 64(1):73-9. PubMed ID: 17665854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of microorganisms in some common excipients used in tablet formulation.
    Obuekwe IF; Eichie F
    Acta Pol Pharm; 2006; 63(2):121-5. PubMed ID: 17514875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of Filler Effects on the Compounding of Freeze-dried Orodispersible Tablets Containing Annona muricata Extract.
    Azman SEN; Abd Razak FS; Kamal WHBW; Zheng GK; Ming LC; Uddin AH; Sarker ZI; Bin LK
    Int J Pharm Compd; 2020; 24(6):509-514. PubMed ID: 33217741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the SeDeM Diagram and a new mathematical equation in the design of direct compression tablet formulation.
    Suñé-Negre JM; Pérez-Lozano P; Miñarro M; Roig M; Fuster R; Hernández C; Ruhí R; García-Montoya E; Ticó JR
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1029-39. PubMed ID: 18367387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations.
    Allen LV
    Int J Pharm Compd; 2023; 27(2):123-139. PubMed ID: 37000138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiologic Testing for 503A Sterile-Compounding Pharmacies.
    Mixon W; Roth A
    Int J Pharm Compd; 2017; 21(3):193-203. PubMed ID: 28557780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleanroom Cleanliness.
    Mulder K
    Int J Pharm Compd; 2021; 25(1):6-12. PubMed ID: 33503004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depyrogenation options for the compounding cleanroom.
    Weller T; Bell J; Dullinger R; Allen V; Anthenat B
    Int J Pharm Compd; 2014; 18(6):446-54. PubMed ID: 25906620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of sustained-release Compritol® 888 ATO matrix mini-tablets.
    Roberts M; Vellucci D; Mostafa S; Miolane C; Marchaud D
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1068-76. PubMed ID: 22149472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basics of Compounding: Compounding Films.
    Allen LV
    Int J Pharm Compd; 2016; 20(4):298-305. PubMed ID: 28333675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compounding slow-release capsules: a comprehensive review and an Excel spreadsheet for faster calculations of excipients.
    Zur E
    Int J Pharm Compd; 2013; 17(1):10-22. PubMed ID: 23627242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes.
    Kushner J; Langdon BA; Hicks I; Song D; Li F; Kathiria L; Kane A; Ranade G; Agarwal K
    J Pharm Sci; 2014 Feb; 103(2):527-38. PubMed ID: 24375069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of moisture content on compression properties of two dextrose-based directly compressible diluents.
    Shukla AJ; Price JC
    Pharm Res; 1991 Mar; 8(3):336-40. PubMed ID: 2052520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basics of Compounding: Excipients Used in Nonsterile Compounding: Diluents.
    Allen LV
    Int J Pharm Compd; 2021; 25(3):218-221. PubMed ID: 34125712
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitative assessment of factors contributing to mottling of colored tablets II: formulation variables.
    Armstrong NA; March GA
    J Pharm Sci; 1976 Feb; 65(2):200-4. PubMed ID: 1255449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A methodological evaluation and predictive in silico investigation into the multi-functionality of arginine in directly compressed tablets.
    ElShaer A; Kaialy W; Akhtar N; Iyire A; Hussain T; Alany R; Mohammed AR
    Eur J Pharm Biopharm; 2015 Oct; 96():272-81. PubMed ID: 26255158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.